Ken Takeshima Selected Research

Ken Takeshima Research Topics

Disease

7	Neoplasms (Cancer) 10/2020 - 01/2017
4	Immunoglobulin G4-Related Disease 07/2021 - 01/2013
4	Thyroiditis 01/2021 - 01/2013
3	Graves Disease (Basedow Disease) 01/2023 - 04/2014
2	Hypoglycemia (Reactive Hypoglycemia) 07/2022 - 01/2018
2	Diabetes Mellitus 04/2021 - 06/2018
2	Thyroid Diseases (Thyroid Disease) 01/2021 - 10/2019
1	Insulin Resistance 07/2023
1	Type 2 Diabetes Mellitus (MODY) 07/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 07/2023
1	Hyponatremia 07/2022
1	COVID-19 07/2022
1	Hypopituitarism (Sheehan's Syndrome) 03/2022
1	Lymphoma (Lymphomas) 03/2022
1	Combined Pituitary Hormone Deficiency 07/2021
1	Autoimmune Hypophysitis 07/2021
1	Ketosis 04/2021
1	Empyema 04/2021
1	Diabetic Ketoacidosis (Ketoacidosis, Diabetic) 04/2021
1	Hypothyroidism 02/2021
1	Follicular Adenocarcinoma 10/2020
1	Acute Liver Failure (Fulminant Hepatic Failure) 09/2020
1	Thyroid Crisis (Thyrotoxic Crisis) 09/2020
1	Disease Progression 09/2020
1	Hyperbilirubinemia 09/2020
1	Heart Failure 09/2020
1	Headache (Headaches) 06/2020
1	Pheochromocytoma 06/2020
1	Paraganglioma (Paragangliomas) 05/2020
1	Pituitary Neoplasms (Pituitary Adenoma) 04/2020
1	ACTH-Secreting Pituitary Adenoma 04/2020
1	Adenoma (Adenomas) 04/2020
1	Addison Disease (Addison's Disease) 04/2020
1	Asthma (Bronchial Asthma) 04/2020
1	Autoimmune Hepatitis 04/2020
1	Adrenocorticotropic hormone deficiency 12/2019
1	Pancreatic Diseases (Pancreatic Disease) 06/2018
1	Autoimmune Pancreatitis 06/2018
1	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2018
1	Paraneoplastic Syndromes (Paraneoplastic Syndrome) 01/2017
1	Hypophosphatemia 01/2017
1	Oncogenic osteomalacia 01/2017
1	Fibrosis (Cirrhosis) 04/2014
1	Mikulicz' Disease 01/2013
1	Exophthalmos (Proptosis) 01/2013

Drug/Important Bio-Agent (IBA)

4	Immunoglobulin G (IgG)IBA 01/2021 - 01/2013
2	VaccinesIBA 01/2023 - 07/2022
2	Messenger RNA (mRNA)IBA 07/2022 - 10/2020
2	SteroidsIBA 07/2021 - 06/2018
2	Prednisolone (Predate)FDA LinkGeneric 07/2021 - 04/2020
2	Immune Checkpoint InhibitorsIBA 05/2020 - 10/2019
2	Immunoglobulins (Immunoglobulin)IBA 01/2015 - 04/2014
1	C-PeptideIBA 07/2023
1	AutoantibodiesIBA 07/2023
1	Thyroxine (Levothyroxine)FDA LinkGeneric 07/2023
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 07/2023
1	mRNA VaccinesIBA 07/2022
1	Adrenocorticotropic Hormone (ACTH)FDA Link 07/2022
1	Hydrocortisone (Cortisol)FDA LinkGeneric 07/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 04/2021
1	Glucose (Dextrose)FDA LinkGeneric 04/2021
1	SodiumIBA 04/2021
1	empagliflozinIBA 04/2021
1	Insulin (Novolin)FDA Link 04/2021
1	ProcalcitoninIBA 10/2020
1	Thyroglobulin FDA Link 10/2020
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 10/2020
1	BilirubinIBA 09/2020
1	CatecholaminesIBA 06/2020
1	Endoplasmic Reticulum Chaperone BiPIBA 06/2020
1	Proteins (Proteins, Gene)FDA Link 06/2020
1	RNA (Ribonucleic Acid)IBA 06/2020
1	Biomarkers (Surrogate Marker)IBA 05/2020
1	Succinate Dehydrogenase (Fumarate Reductase)IBA 05/2020
1	Transcription Factors (Transcription Factor)IBA 04/2020
1	B7-H1 AntigenIBA 04/2020
1	MutS ProteinsIBA 04/2020
1	AntigensIBA 12/2019
1	Adrenal Cortex Hormones (Corticosteroids)IBA 06/2018
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 01/2018
1	SubtilisinIBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Testosterone (Sustanon)FDA Link 01/2018
1	Ga(III)-DOTATOCIBA 01/2017
1	Phosphates (Orthophosphate)IBA 01/2017
1	Edotreotide (SMT 487)IBA 01/2017
1	Somatostatin Receptors (Somatostatin Receptor)IBA 01/2017
1	Fibroblast Growth Factor-23IBA 01/2017
1	Troleandomycin (TAO)FDA Link 01/2013

Therapy/Procedure

7	Therapeutics 07/2021 - 01/2018
1	Glycemic Control 07/2023
1	Drug Therapy (Chemotherapy) 03/2022
1	Contraindications 09/2020
1	Plasma Exchange 09/2020
1	Adrenalectomy 06/2020
1	Thymectomy 04/2020